Xiaoping Ju

465 total citations
28 papers, 259 citations indexed

About

Xiaoping Ju is a scholar working on Radiation, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoping Ju has authored 28 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiation, 16 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoping Ju's work include Advanced Radiotherapy Techniques (19 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Glioma Diagnosis and Treatment (7 papers). Xiaoping Ju is often cited by papers focused on Advanced Radiotherapy Techniques (19 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Glioma Diagnosis and Treatment (7 papers). Xiaoping Ju collaborates with scholars based in China. Xiaoping Ju's co-authors include Xiaofei Zhu, Yangsen Cao, Huojun Zhang, Fei Cao, Yuxin Shen, Fang Fang, Zhenyu Jia, Xianzhi Zhao, Zhiyong Yuan and Xueling Guo and has published in prestigious journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Xiaoping Ju

27 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoping Ju China	10	172	107	98	74	62	28	259
Yangsen Cao China	10	180 1.0×	105 1.0×	98 1.0×	76 1.0×	62 1.0×	30	255
Ryan Assadi United States	4	245 1.4×	130 1.2×	42 0.4×	58 0.8×	73 1.2×	6	313
Antonio Stefanelli Italy	9	102 0.6×	130 1.2×	40 0.4×	64 0.9×	37 0.6×	38	287
Simul Parikh United States	6	244 1.4×	146 1.4×	66 0.7×	37 0.5×	99 1.6×	9	362
Ronan Tanguy France	10	80 0.5×	229 2.1×	106 1.1×	62 0.8×	39 0.6×	30	322
Carlene L. Chun United States	6	212 1.2×	102 1.0×	52 0.5×	23 0.3×	91 1.5×	11	314
Richie Sinha Canada	5	281 1.6×	267 2.5×	84 0.9×	90 1.2×	50 0.8×	5	426
D.J. DiCostanzo United States	10	82 0.5×	117 1.1×	91 0.9×	62 0.8×	92 1.5×	29	267
Oyeon Cho South Korea	12	202 1.2×	96 0.9×	38 0.4×	53 0.7×	61 1.0×	28	378
Tse-Kuan Yu United States	9	229 1.3×	96 0.9×	61 0.6×	55 0.7×	208 3.4×	9	382

Countries citing papers authored by Xiaoping Ju

Since Specialization

Citations

This map shows the geographic impact of Xiaoping Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Ju more than expected).

Fields of papers citing papers by Xiaoping Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Ju. The network helps show where Xiaoping Ju may publish in the future.

Co-authorship network of co-authors of Xiaoping Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Ju. A scholar is included among the top collaborators of Xiaoping Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Ju. Xiaoping Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Chenyang, Xianzhi Zhao, Xiaoping Ju, et al.. (2022). Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China. Frontiers in Oncology. 12. 879310–879310. 1 indexed citations

Zhu, Xiaofei, Wenyu Liu, Yangsen Cao, et al.. (2022). Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: a secondary analysis of an open-label, randomised, controlled, phase 2 trial. EClinicalMedicine. 55. 101764–101764. 8 indexed citations

Zhao, Xianzhi, Haiyan Yu, Chao Cheng, et al.. (2021). Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China. Journal of Cancer Research and Clinical Oncology. 147(12). 3557–3564. 4 indexed citations

Zhu, Xiaofei, Wenyu Liu, Yangsen Cao, et al.. (2021). Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy. Frontiers in Oncology. 11. 688576–688576. 3 indexed citations

Zhu, Xiaofei, et al.. (2021). Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial. Radiotherapy and Oncology. 162. 178–184. 7 indexed citations

Shen, Yuxin, Xiaofei Zhu, Fei Cao, et al.. (2021). Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases. Frontiers in Oncology. 11. 729490–729490. 5 indexed citations

Wan, Liu, Yingxian Sun, Guang Yu, et al.. (2020). Protective Effects on Hypoxia Reoxygenation Cardiomyocytes by GLP-1R Agonists via PI3K/AKT Signaling Pathway. International journal of gerontology. 14(3). 168–173. 2 indexed citations

Zhao, Xianzhi, Xiaofei Zhu, Hongqing Zhuang, et al.. (2020). Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China. Scientific Reports. 10(1). 7836–7836. 14 indexed citations

Zhu, Xiaofei, Di Chen, Yangsen Cao, et al.. (2020). Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications. Cancer Biology and Medicine. 17(2). 492–500. 1 indexed citations

10.

Gu, Lei, Xiaofei Zhu, Xiaoping Ju, et al.. (2019). Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis. Frontiers in Oncology. 9. 1352–1352. 7 indexed citations

11.

Zhu, Xiaofei, Xiaoping Ju, Yangsen Cao, et al.. (2019). Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design. International Journal of Radiation Oncology*Biology*Physics. 104(1). 101–110. 48 indexed citations

12.

Zhu, Xiaofei, Dongchen Shi, Xiaoping Ju, et al.. (2018). Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer. Cancer Management and Research. Volume 10. 4805–4815. 6 indexed citations

13.

Cao, Yangsen, Xiaofei Zhu, Xiaoping Ju, et al.. (2018). Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells. Radiation Oncology. 13(1). 11–11. 9 indexed citations

14.

Zhu, Xiaofei, Wenyu Liu, Dongchen Shi, et al.. (2018). Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database. Cancer Management and Research. Volume 10. 1295–1304. 13 indexed citations

15.

Zhu, Xiaofei, Xiaoping Ju, Yuxin Shen, et al.. (2018). Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score). Radiotherapy and Oncology. 129(2). 313–318. 12 indexed citations

16.

Zhao, Xianzhi, Xiaofei Zhu, Hai‐Peng Ren, et al.. (2018). Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer. Radiation Oncology. 13(1). 205–205. 19 indexed citations

17.

Ju, Xiaoping, et al.. (2017). Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study. Radiation Oncology. 12(1). 6–6. 8 indexed citations

18.

Cao, Fei, Xiaoping Ju, Di Chen, et al.. (2017). Phosphorothioate-modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy. Molecular Medicine Reports. 16(2). 2089–2094. 8 indexed citations

19.

Cao, Yangsen, Xiaofei Zhu, Yongming Liu, et al.. (2017). A modified formula for dose calculations of stereotactic ablative body radiotherapy for non–small cell lung cancer. Medical dosimetry. 43(3). 207–213. 1 indexed citations

20.

Zhu, Xiaofei, Xiaoping Ju, Fei Cao, et al.. (2016). Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. BMJ Open. 6(12). e013220–e013220. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact